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In plasma, HDL is not a single entity but rather exists as a complex and dynamic mixture of subclasses that differ in size as well as cholesterol, lipid and protein composition [31, 32] .
These differences endow each HDL subclass with unique physiological properties with respect to receptor affinity, enzyme and protein association, cholesterol efflux capacity, size and stability [31, 32] . Subclass-specific properties are important aspects of RCT, where HDL must first accept lipids, become stabilized for transport through the bloodstream and then offload its lipid cargo at target tissues [31, 32] . ApoA-I, the key protein component of plasma HDL, is expressed in liver and intestine and upon synthesis is rapidly lipidated by ABCA1 to form nascent discoidal HDL particles, with liver ABCA1 generating approximately 70% of plasma HDL whereas intestinal ABCA1 contributes the remaining 30% [33, 34] . These newly synthesized nascent HDL particles have a discoidal shape, are composed of two or three molecules of apoA-I and form several distinct particle subtypes [1] . For example, reconstituted nascent apoA-I HDL particles range from 7.8 to 17.0 nm in diameter and differ in their abilities to stimulate ABCA1-dependent cholesterol efflux and to bind and activate lecithin cholesterol acyltransferase (LCAT) [1] . The LCAT reaction converts free unesterified cholesterol to cholesteryl ester (CE) during the maturation of immature nascent discoidal particles to mature spherical HDL [35] , which is the preferred substrate for SR-BI-mediated cholesteryl ester (CE) uptake by the liver and steroidogenic organs [36] .
Compared to nascent apoA-I HDL particles in the periphery, less is known about the structure, function and metabolism of nascent apoE-HDL particles in the brain. Previous studies have shown that nascent apoE and apoJ are secreted as distinct particles from cultured primary astrocytes [37, 38] . After 72 h of media conditioning, apoJ is found on particles approximately 8-Journal of Lipid Research; Full-length regular research articles minutes to remove any remaining cells, then concentrated 10 X using Vivaspin 15 centrifugal concentrators with a molecular weight cut-off of 10,000 Daltons (Sartorius Mechatronics). GCM was stored at -20 o C until analyzed. For cellular analysis, cells from one T75 flask were collected after incubating with 3 ml of 0.25% trypsin with EDTA for 5 min and centrifugation at 1,000 x g for 3 min. Cell pellets were washed once with PBS. For protein analysis, cell pellets were lysed in 500 l of RIPA lysis buffer (20 mM Tris, 1% NP40, 5 mM EDTA, 50 mM NaCl, 10 mM Na pyrophosphate, 50 mM NaF, and Complete protease inhibitor, pH 7.4). Cell lysates were sonicated at 30% output for 10 sec. Overall protein concentration was determined by Lowry protein assay (Bio-rad, Hercules, CA). Glial lysate samples were kept at -80 o C until analyzed by 10% SDS-PAGE.
Fluoresecent Activated Cell Sorting (FACS)
Mixed glial cells were detached from a T75 culture flask with 0.25% trypsin for no more than 2 min, washed 3 times with ice-cold PBS and triturated to a single cell suspension in FACS buffer Data was acquired and analyzed using CellQuestPro software (Becton Dickinson).
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Conditioned media exchange
72 h conditioned media were collected from a whole T75 flask of wild-type or ABCA1-/-primary glia and centrifuged at 1,000 x g for 3 min to remove cellular debris. Half of the collected media was stored at -20°C and the other half was transferred to a T75 flask of apoE-/-glia for another 48 h incubation. All collected media were concentrated 10X as above prior to analysis.
Electrophoresis and Western blotting
For native PAGE, GCM samples were mixed with non-denaturing loading dye to a final concentration of 0.04% bromophenol blue, 4.0% glycerol and 100 mM Tris pH 6.8) and resolved on 6% non-denaturing Tris-HCl polyacrylamide gels. For SDS-PAGE, media and cell samples were mixed with loading dye containing 2% SDS and 1% -mercaptoethanol, incubated for 10 min The Biodesign antibody to human apoE cross-reacts with murine apoE. Membranes were washed with 2xPBS-T (2xPBS with 0.05% Tween-20) 4 times for 8 min each and incubated for 1 h with 1:1000 horseradish peroxidase (HRP)-labeled anti-goat secondary antibody (Santa Cruz). Results were visualized using chemiluminescence (ECL, Amersham, New Jersey, USA). Particle diameters on native gels were determined by comparison with a native high molecular weight marker standard (Amersham). Protein molecular weights on denaturing gels were determined by comparison with the Kaleidoscope molecular weight marker standard (BioRad).
Potassium bromide (KBr) gradient ultracentrifugation
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Journal of Lipid Research; Full-length regular research articles Three ml of CGM, conditioned for 72 h and concentrated 5 X, was adjusted to a density of 1.25 g/ml with KBr salt and overlaid with 2.0 ml of 1.225 g/ml, 4.0 ml of 1.100 g/ml and 3.0 ml of 1.006 g/ml KBr solutions. Gradients were centrifuged for 21h 15 min at 40,000 rpm at 20°C in a SW41 rotor (Beckman). Four fractions were collected from the top of the gradient: Fraction 1 = 4 ml (1.060 g/ml), fraction 2 = 3 ml (1.122 g/ml), fraction 3 = 3 ml (1.195 g/ml) and fraction 4 = 2 ml (1.252 g/ml). Fractions were dialysed against PBS at 4°C overnight, then concentrated 10 X using Centriprep YM-10 concentrators with molecular weight cut-off of 10,000 Daltons (Millipore) and analysed by 6% native PAGE and 10% SDS-PAGE. TC content of fractions was measured using commercially availalble enzymatic kits (Invitrogen) following the manufacturer's instructions.
Electron microscopy
350 L of concentrated GCM was dialyzed against electron microscopy (EM) dialysis buffer (0.125 M ammonium acetate, 2.6 mM ammonium carbonate and 0.26 mM EDTA) overnight at 4 o C. 2 L of each sample was then mixed with 2L of 2% sodium phosphotungstate and incubated for 1 min. 5 L of the stained sample was loaded onto formvar-and carbon-coated copper grids (Canemco). Excess solution was immediately absorbed with filter paper and the sample was air-dried on the grid. Particles were imaged on a Hitachi H7600 transmission electron microscope using an AMT Advantage HR Digital CCD camera.
Oil-Red-O staining
Glial cells were seeded in poly-D-lysine coated 12-well plates at 300,000 cells/well. and another 1 mL of fresh protease buffer was added to the beads and incubated at RT overnight.
Eluate samples were pooled and concentrated 10 X using Centriprep YM-10 concentrators (Millipore) and analysed on a 10% SDS-PAGE gel stained with Coomassie Blue for quantification.
RAP inhibition of apoE uptake
Wild-type and ABCA1-/-glia were reseeded into 12-well plates at a density of 400,000-500,000 cells/well in 1 mL of maintenance media (DMEM:F12 containing 10% FBS, 2 mM L-glutamine, 1% penicillin/streptomycin). After 48 h, cells were treated with either 500 L of serum-free conditioning Plates were read at 450nm absorbance.
Cholesterol and Phospholipid Measurement
Total cholesterol measurements of GCM samples were performed using the fluorogenic Amplex After the lipid pellet was dissolved in 2% Triton-X 100, cellular total cholesterol and phospholipids content were measured by Wako kits following the manufacture's protocols (Wako #439-35801 for Cholesterol E kit, #433-36201 for Phospholipids C kit).
Preparation of recombinant apoA-I
Human apoA-I was expressed in bacteria as previously described [41] . The protein was expressed in Escherichia coli strain BL21 (DE-3) pLysS and cultured in NZCYM media containing 50 µg/ml ampicillin. Expressed proteins were purified via Hi-Trap nickel chelating columns (GE Biosciences, Inc., Piscataway, NJ) as described [41] . Protein purity (>95%) was confirmed by SDS-PAGE.
Statistical analysis
Data are shown as mean ± standard error. One-way ANOVA with a Tukey's Multiple Comparison post test or two-tailed unpaired Student's t-tests were used for statistical analysis. For t-test analyses, Welch's correction for unequal variances was applied when variances were significantly different between groups. All statistical analyses were performed using GraphPad Prism (version 5.0; GraphPad Software for Science Inc., San Diego, CA).
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Results

Nascent apoE particle subspecies are secreted from WT and ABCA1-/-glia in a distinct temporal pattern
Previous studies have suggested that ABCA1-/-glia secrete less apoE within the first 6-8 h of conditioning compared to WT glia but that total apoE levels become equivalent after 72 h [5, 6] .
To further delineate the dynamic nature of glial apoE secretion, we characterized the electrophoretic pattern of apoE subspecies secreted from mixed primary WT and ABCA1-/-glia after 6, 24, 48, and 72 h of conditioning. FACS analysis shows that WT and ABCA1-/-cultures contain comparable amounts of GFAP-positive astrocytes and CD11b-postiive microglia (astrocytes: WT= 80.71 ± 4.73 %, N=5, ABCA1= 84.07 ± 3.39%, N=5, p>0.05; Microglia: WT= 2.68 ± 1,17 %, N=5, ABCA1= 3.25 ± 1.95 %, N=5, p>0.05). Native PAGE analysis shows that WT glia secrete several apoE nascent particles ranging in diameter from approximately 7.5 -17 nm, including an 8.1 nm species that requires at least 48 h of conditioning to become detectable in WT glial conditioned media (GCM) (Fig. 1) . ABCA1-/-glia secrete only the 8.1 nm particle. SDS page analysis confirms that ABCA1-/-glia secrete less total apoE during the first 6 h of conditioning.
The 8.1 nm particle secreted from WT and ABCA1-/-glia is a lipid poor and structurally distinct species Wahrle et. al. previously reported that the total cholesterol (TC) content of conditioned media from ABCA1-/-astrocytes is reduced by 70% compared to WT controls [6] , indicating that the 8.1 nm species is lipid poor. To confirm this observation, we quantified the TC and total apoE levels in 72h GCM by enzymatic assay and ELISA, respectively, and observed a 79% decrease in TC (WT:
72.3 g TC/g apoE; ABCA1-/-: 15.1 g TC/g apoE, p<0.001), consistent with Wahrle's earlier observation [6] . To determine if there were differences in lipidation of individual glial-derived nascent apoE subspecies, we next performed KBr gradient ultracentrifugation to separate the 2A ). In contrast, the 8.1 nm particle from both WT and ABCA1-/-glia was recovered in fraction 4 (> 1.25 g/ml) (Fig. 2A) . ApoJ, a protein-dense lipoprotein secreted from glia, is also recovered in fraction 4 from both WT and ABCA1-/-media (Fig. 2A) . These observations indicate that the 8.1 nm particle, detectable in WT GCM by 48-72 h, is equivalent to the 8.1 poorly lipidated species that is the sole apoE particle found in ABCA1-/-GCM. Negative staining EM of conditioned media from WT and ABCA1-/-glia revealed that rouleaux characteristic of discoidal HDL particles was observed in WT but not ABCA1-/-samples, suggesting that the 8.1 nm particle is nondiscoidal and structurally incapable of forming these distinctive stacks (Fig. 2B) .
Lipidation of the 8.1 nm apoE particle by ABCA1 restores apoE subspecies distribution to resemble the WT pattern Because the 8.1 nm apoE particle is a structurally distinct lipid-poor HDL particle relative to the other nascent apoE HDL particles secreted by WT glia, we next queried whether it was capable of accepting lipids from ABCA1. Media from WT and ABCA1-/-glia were conditioned for 72 h and then added to apoE-/-glia for an additional 48 h to allow the donor particles to be lipidated by ABCA1 expressed in the recipient cells. Donor apoE particles secreted from both WT and ABCA1-/-glia gave rise to a nearly identical pattern of apoE particles after incubation with ABCA1-expressing apoE-/-glia (Fig. 3) . The only particle that ABCA1-/-donor media failed to generate was a large species at approximately 17 nm. These observations demonstrate that despite its structurally distinct nature, the 8.1 nm apoE particles are not impaired in their ability to accept lipids from ABCA1. [5] . We confirmed and extended these observations by first staining for neutral lipids using Oil-Red-O in WT, ABCA1-/-and LDLR-/-glia. As expected, we observed minimal lipid droplets in WT glia, abundant lipid droplets in ABCA1-/-glia and no lipid accumulation in LDLR-/-glia (Fig. 4A) . Because cellular lipid accumulation in ABCA1 -/-cells is expected to activate SREBP2 that leads to negative feedback regulation of LDLR but not LRP expression, we next quantified LDLR and LRP levels by Western blot. As expected from the presence of lipid accumulation, ABCA1-/-cells exhibited a 75% reduction in LDLR protein levels compared to WT glia (p < 0.0001, Fig. 4B ) but no significant change in LRP levels compared to WT glia. The selective reduction in LDLR levels in ABCA1-/-glia indicates that the ratio of LRP:LDLR is likely lower in ABCA1-/-relative to WT glia under the culture conditions employed. There were no significant differences in cellular apoE levels among WT, ABCA1-/-and LDLR-/-glia (Fig. 4B) .
ABCA1 deficiency reduces LDLR levels in cultured glia
Inhibition of apoE receptor activity preferentially reduces secretion of small apoE particles from glia
In several cell types, apoE is recycled through apoE-receptor mediated endocytosis and resecretion [42] [43] [44] [45] . To determine if apoE recycling also occurs in primary glia, we first examined the distribution pattern of secreted apoE particles over time in WT and LDLR-/-glia. Appearance of apoE particles in LDLR-/-GCM was delayed relative to WT GCM (Fig. 5) . Furthermore, the 8.1 nm apoE particle was barely detectable even after 96h of conditioning (Fig. 5) . Selective deletion of the LDLR did not alter cellular TC content in LDLR-/-compared to WT glia (WT = 27.09 ± 2.232 ng TC/ng protein, N=4, LDLR-/-= 25.78 ± 1.111 ng TC/ng protein, N=5, p=0.592). These observations are consistent with a role for LDLR in apoE recycling and that the 8.1 nm particle is particularly affected by loss of LDLR activity.
To further differentiate the roles of glial LRP and LDLR on secretion of apoE subspecies, we also used recombinant RAP, prepared as a GST-fusion protein, to block the activity of apoE Journal of Lipid Research; Full-length regular research articles receptors. RAP inhibits LRP at 70 nM and both LRP and LDLR at 1 M [46] . The levels and pattern of secreted apoE subspecies were not altered when WT, ABCA1-/-and LDLR-/-glia were incubated with 1 M BSA as a negative control or with 70 nM RAP, suggesting that LRP does not play a major role in regulating the levels of secreted apoE (Fig. 6A, left panel) . In contrast, treatment of WT and LDLR-/-glia with 1 M RAP reduced the total level of secreted apoE, as well as preferentially inhibited the secretion of the smaller apoE subspecies, leaving only the larger 12-17 nm particles evident in GCM (Fig. 6A, left panel) . Although treatment of ABCA1-/-glia with 70 nM RAP had no impact on secreted apoE levels, treatment with 1 M RAP blocked the secretion of the 8.1 nm apoE species, virtually eliminating the secretion of apoE (Fig. 6A, left and right   panels) . That functional inhibition of apoE receptors reduces secreted apoE is consistent with the hypothesis that apoE recycling, primarily via LDLR, contributes to the steady state apoE levels in GCM. Furthermore, by inhibiting apoE uptake, RAP-mediate inhibition of glial apoE receptors may prolong the extracellular half-life of secreted apoE and increase its availability to ABCA1, thus generating larger particles in cells that are capable of cholesterol efflux.
To specifically delineate the contribution of LDLR to apoE recycling in glia, we generated double ABCA1/LDLR-/-mice and evaluated apoE secretion from primary mixed glia.
Densitometric analysis of apoE levels in GCM by SDS-PAGE suggests at least a 70% reduction in total apoE levels in 72 h DKO GCM (WT: 7.33 +/-4.17 optical units, ABCA1-/-: 7.21 +/-4.23 optical units, DKO: 2.12 +/-1.01 optical units) (Fig. 6B) . More accurate quantitation of total apoE levels by ELISA shows that apoE secretion is reduced by approximately 93% in 72 h DKO GCM (WT: 123.5 +/-1.66 ng/ml, ABCA1-/-: 123.9 +/-10.83 ng/ml, DKO: 8.72 +/-1.13 ng/ml) (Fig. 6C) .
Because LDLR levels in ABCA1-/-glia are only approximately 25% of WT levels under the culture conditions employed here (Fig. 6B,C) , these observations clearly define a major role for the LDLR in ABCA1-independent apoE recycling/secretion, as LRP cannot compensate efficiently for LDLR with respect to apoE recycling.
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ApoA-I stimulates glial apoE recycling and lipidation in primary glia
ApoA-I and HDL have been reported to stimulate apoE recycling in a wide variety of cell types including Chinese hamster ovary (CHO) cells, fibroblasts, hepatocytes, macrophages, adipocytes and neuronal cells [42, [47] [48] [49] [50] [51] [52] [53] [54] [55] . In macrophages, apoA-I-mediated stimulation of apoE secretion is independent of ABCA1 [56] . To determine whether apoA-I stimulates apoE secretion from primary glia, we treated mixed glial cultures with recombinant human apoA-I at doses ranging from 10-60 g/ml for 48 h. Conditioned media showed a clear dose-dependent increase in 8.1nm apoE particles (Fig. 7A) , supporting our hypothesis that this species represents recycled apoE that, in WT cells, has not yet been lipidated by ABCA1. The decreased signal of larger particles (>10nm) in WT media suggested that secreted apoE might be driven more towards the recycling pathway rather than lipidation in the presence of apoA-I. ApoA-I treatment of WT glia also led to a significant increase in cellular LDLR levels, further supporting a role for LDLR in glial apoE recycling (Fig. 7B, C) . It also led to trends toward increased ABCA1 and decreased cellular apoE levels (Fig. 7B, C) . Cellular LRP levels were not significantly affected by apoA-I treatment (Fig.   7B, C) .
.
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Discussion
ApoE is at the hub of CNS HDL metabolism and the most important genetic risk factor for sporadic AD. Several lines of evidence suggest that aberrant CNS lipid metabolism may contribute to AD pathogenesis [9] . Of particular interest is the discovery that ABCA1-mediated lipidation of apoE facilitates the degradation and clearance of A peptides, potentially offering a mechanism for novel therapeutic strategies for AD. Developing such therapeutic approaches will likely require a deeper understanding of the metabolism of brain HDL particles than presently exists. It is likely that CNS apoE-HDL comprise distinct specialized lipoprotein subspecies, similar to complexity of plasma HDL, which are a heterogeneous mixture of subclasses with both structural and functional differences [1, 32] . In this paper we provide evidence for structural and physiological differences in nascent apoE-derived lipoproteins secreted from glia.
ApoE appears in glial-conditioned media as a variety of nascent particles ranging from 7.5 -17 nm in diameter, a larger size range than previously reported [6, 19, 37, 38] . Most of the earlier studies have allowed media to condition for extended periods of time (i.e. 72h) to allow apoE to accumulate to sufficient levels for detection. We analyzed secreted apoE subspecies from 6-72 h and demonstrate that particle diameters are modulated over this time course, suggesting that there may be extensive remodeling of apoE species that could occur through direct interaction among secreted particles in the media, through interactions at the cellular membrane, or via apoE uptake and recycling mediated by apoE receptors.
In particular, both WT and ABCA1-/-glia secrete an 8.1 nm apoE particle that is structurally and functionally distinct from the other species secreted from WT cells. We hypothesize that this particle is recycled apoE that emerges from the cell in a lipid-poor state independent of ABCA1 and rapidly lipidated if cells express functional ABCA1. Supporting this hypothesis are the following observations. First, the 8.1 nm particle is lipid poor. The 8.1 nm particle is the sole species secreted from ABCA1-/-glia, and previous studies using gel filtration Journal of Lipid Research; Full-length regular research articles chromatography and media TC measurements have demonstrated its paucity of lipids [6] . Here we show that this 8.1 nm particle is also detectable in WT GCM and that it resolves in a lipid-poor fraction by KBr density gradient ultracentrifugation when isolated from either WT or ABCA1-/-glia. Second, it is structurally distinct from the other apoE species. Negative staining EM indicates that it is unable to form rouleaux characteristic of discoidal lipoprotein particles, consistent with the "figure-8" structure for similarly sized peripheral apoA-I -containing HDL particles predicted by Catte et al [57] and observed by Cavigiolio et al [58] and Zhang et al [59] . Nevertheless, it is not a dead-end particle with respect to RCT, as conditioned media swap experiments demonstrate that it is fully capable of accepting lipids effluxed by ABCA1 to form the full repertoire of particles normally observed in WT GCM. Third, blocking apoE receptor function by RAP inhibits the appearance of the 8.1 nm particle from ABCA1-/-glia, suggesting that it may arise through an ABCA1-independent recycling pathway dependent on apoE receptors.
Our data suggests that apoE may be recycled primarily through LDLR in glial cultures. In ABCA1-/-glia, accumulation of lipid droplets triggers feedback regulation that suppresses LDLR expression to approximately 25% of normal levels, but does not significantly impair apoE secretion after extended conditioning periods. However, decreasing LDLR levels from 25% to zero by selectively deleting LDLR in ABCA1-/-glia greatly impedes apoE secretion to approximately 10% of WT levels. Further, RAP added to levels that would reduce only LRP function did not have an effect on apoE secretion from WT or ABCA1-/-glia, but addition of 1 M RAP to inhibit both LRP and LDLR markedly impaired apoE secretion from ABCA1 -/-cells. These findings suggest that even though LRP is abundantly expressed in ABCA1-/-glia, it does not compensate well for LDLR in glial apoE recycling.
Intriguingly, lipid-poor apoE particles secreted from human embryonic kidney (HEK) cells were found to self-assemble into a high MW mass that bound more avidly to LRP than LDLR [60] .
This may be due to the size of these high MW species, as small apoE-containing triglyceride-rich emulsions have impaired LDLR-dependent clearance in rats but emulsions of large particles are Journal of Lipid Research; Full-length regular research articles cleared independently of LDLR [61] . Experiments in primary hepatocytes showed that apoE reconstituted into VLDL particles is recycled normally in LDLR-/-cells even though uptake is reduced by 50% [62] . Similar experiments using RAP-/-hepatocytes, which have a 75% reduction in LRP levels, also indicated apoE is recycled normally [62] . These results suggest that in hepatocytes, efficient apoE recycling can be mediated by either LDLR or LRP, at least when apoE is reconstituted in VLDL particles. Whether recycling of small nascent apoE-only particles may have a preference for LDLR or LRP in hepatocytes is not yet known. Understanding the differences between high MW HEK-derived apoE particles, reconstituted apoE-VLDL particles and nascent glial-derived apoE particles may offer insight into the factors that govern apoE receptor preference.
Taken together, these results define two pathways that regulate the steady state levels of glial-derived secreted apoE. One pathway requires ABCA1 and leads to the accumulation of several lipidated discoidal nascent apoE particles from 7-17 nm in diameter. The other pathway requires functional apoE receptors, primarily LDLR, and selectively regulates the secretion of a distinct 8.1 nm poorly lipidated apoE species, which is likely re-secreted following LDLR-mediated apoE uptake. Secretion of this particle does not require ABCA1, but when ABCA1 is present the particle is rapidly lipidated and difficult to detect in WT GCM.
Previous studies suggest that 60-80% of internalized apoE may be recycled [42] [43] [44] [45] and directed to HDL particles [63] in non-CNS tissues. For example, triglyceride-rich lipoproteins taken up by hepatocytes via apoE receptors are differentially sorted after endocytosis. Core lipids and apoB are targeted to lysosomes whereas the majority of apoE is delivered to recycling endosomes where it can be mobilized by apoA-I or HDL to be recycled back to the plasma membrane followed by resecretion and relipidation of apoE to form apoE-HDL [42, 49] . In macrophages, FPLC analysis demonstrates that recycled apoE is present on small HDL, suggesting that it either exits the cell in a lipidated form or is swiftly lipidated by ABCA1 [50] . The results presented in this paper suggest that glia also share these pathways.
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Journal of Lipid Research; Full-length regular research articles HDL or purified apoA-I stimulates the release of internalized apoE from CHO cells, hepatocytes, fibroblasts, adipocytes, macrophages and neuronal cells [42, [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] . The mechanism by which apoA-I or HDL stimulates apoE recycling is not yet clear. In hepatoma cells, HDL-derived apoA-I colocalizes with apoE in EEA-1 positive early endosomes [48] . ABCA1 colocalizes with internalized apoA-I in macrophages [64] and modulates late endocytic trafficking [65] . These observations suggest that ABCA1, apoA-I and apoE may have intracellular interactions that promote apoE recycling. Much remains to be learned, however, as internalized apoA-I is apparently not resecreted efficiently and has been reported to contribute to only 1.4% of total HDL production [66] . Further, because secreted apoE levels are equivalent between WT and ABCA1-/-glia after extended conditioning times [6] , ABCA1 is clearly not required for apoE recycling in glia. These observations parallel the previous observation that apoA-I stimulates apoE secretion from macrophages independent of ABCA1 [56] .
Because most of the apoA-I in the CNS is found in CSF and is not synthesized by glia [16, 17, 19] , the relevance of apoA-I-mediated stimulation of apoE recycling in the CNS is not immediately evident. However, several recent studies suggest that apoA-I affects CNS function and impacts the pathogenesis of AD. For example, although deletion of apoA-I alone has no effect on memory, apoA-I-/-mice crossed with the APP/PS1 mouse model of AD exhibit increased inflammation and impaired spatial learning and memory retention compared to APP/PS1 controls [67] . Conversely, two-fold over-expression of apoA-I protected APP/PS1 mice from inflammation and age-associated learning and memory deficits [68] . These changes were independent of APP processing, did not influence soluble or insoluble Aβ 40 or Aβ 42 levels or amyloid plaque burden [67] [68] [69] and did not affect the levels of brain apoE [67, 69] , ABCA1 [67] , or cholesterol content [67, 68] . However, APP/PS1 apoA-I-/-mice showed a 10-fold increase in insoluble Aβ 40 and a 1.5-fold increase in Aβ 42 in cortical and hippocampal blood vessels, indicating that these mice have significantly increased cerebral amyloid angiopathy (CAA) [67] .
In contrast, levels of CAA were decreased by 44% in APP/PS1 mice over-expressing apoA-I Fan et al, pg 22
Journal of Lipid Research; Full-length regular research articles [68] . These studies demonstrate that although apoA-I is not a major apolipoprotein in brain parenchyma, it nevertheless can influence inflammation, cognitive function and Aβ metabolism in the cerebral vasculature. Whether brain delivery of apoA-I can be used to stimulate apoE recycling and promote brain RCT now becomes an important question to pursue.
The relevance of this question is highlighted by recent findings on the importance of apoE genotype on recycling and brain physiology. ApoE4 is impaired in HDL-induced recycling of TRLs [70] . Furthermore, the low pH of lysosomes may preferentially affect the molten globule structure of apoE4 that retards its release into the recycling pathway [71] [72] [73] [74] . ApoE3 binds HDL more readily than apoE4 [75] , suggesting that it may be more efficiently stimulated by HDL or apoA-I to enter the recycling pathway. Recently, expression of apoE4 in neurons was shown to impair glutamate receptor function and apoer2 receptor recycling by sequestering NMDA, AMPA, and apoer2 receptors intracellularly, thereby reducing their cell surface expression [76] .
As such, Reelin-induced long-term potentiation (LTP) is reduced, ultimately leading to impaired synaptic plasticity [76] . Our results show that apoA-I stimulation of apoE recycling in glia increases LDLR levels in WT and ABCA1-/-glia. Future studies will address whether apoA-I can rescue impaired recycling of receptors in apoE4-expressing cells.
Another question raised by our study is whether stimulating apoE recycling may be beneficial or detrimental with respect to A clearance and AD pathogenesis. On one hand, increasing apoE recycling may promote brain RCT and elevate glutamate receptor levels.
Stimulation of recycling may correct the relative deficit of apoE4 in brain and CSF, as the net levels of apoE4 are lower in brain, CSF and plasma of human apoE4 targeted replacement mice compared to apoE2 and apoE4 controls [77] . Several other human and animal studies have also reported reduced apoE4 levels in brain [78] [79] [80] [81] [82] but this is not always observed [83] [84] [85] . On the other hand, our data would suggest that recycled apoE emerges as a lipid-poor particle that, unless rapidly lipidated by ABCA1, would be expected to promote amyloidogenesis [25, 26, 86] . 
